RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation

Lung Cancer ◽  
2015 ◽  
Vol 90 (3) ◽  
pp. 477-483 ◽  
Author(s):  
Tatsuya Yoshida ◽  
Kiyotaka Yoh ◽  
Seiji Niho ◽  
Shigeki Umemura ◽  
Shingo Matsumoto ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Egfr Mutation ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Lung Cancer Patients ◽  
Inhibitor Treatment
Sign in / Sign up

Export Citation Format

Share Document